Rhythmic Auditory Stimulation on Upper-limb Movements in PD Patients
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Nov 24, 2022
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how rhythmic auditory stimulation (RAS) can help improve arm movements and functions in patients with Parkinson's disease (PD). The study will take place over 21 days and will compare the effects of training with RAS to see how it helps with movement difficulties commonly experienced by people with PD. The researchers are especially interested in whether the benefits last even after the training ends, with follow-up assessments one month later.
To participate in this trial, applicants should be between 65 and 74 years old and have a diagnosis of idiopathic Parkinson's disease, which means their condition is not caused by another disease. They should have mild to moderate movement issues, be able to understand instructions, and have been on stable medication for at least a month before joining. Participants will be trained to use rhythm in their movements, which could potentially lead to improvements in their daily activities. It's important to know that the trial is not yet recruiting, so there will be more information available as it gets started.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • idiopathic PD diagnosed by a neurologist based on the Movement Disorders Society clinical diagnostic criteria;
- • the Hoehn and Yahr stage is 2 or 3, meaning that bilateral movement problems or combination with mild postural instability;
- • a score of Montreal Cognitive Assessment is equal to or higher than 21 to ensure that they understand experimental instructions;
- • a score of Edinburgh Handedness Inventory is above 60 to ensure that they are right-handed;
- • types and doses of medications remain unchanged in the past month right before participation.
- Exclusion Criteria:
- • the presence of medical conditions or diseases that may affect hand movements, vision, or hearing based on self-report.
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Wei FAN (PhD student), MSc
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials